Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?

The incidence of multiple myeloma (MM), a bone marrow (BM) resident hematological malignancy, is increasing globally. The disease has substantial morbidity and mortality and remains largely incurable. Clinical studies show that autologous stem cell transplantation (ASCT) remains efficacious in eligi...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Simone A. Minnie, Geoffrey R. Hill
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Subjects:	myeloma stem cell transplantation immunotherapy T cells autologous
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.651288/full